Insights - Prosensa (RNA) will seek FDA and European approval for drisapersen, its drug candidate for Duchenne Muscular Dystrophy, following correspondence with the US regulatory body and what appears … Continue Reading
Read NowInsights - Ventrus and Assembly Pharma plan to merge to develop their novel HBV te.chnology
Read NowInsights - The FDA extended the approval decision date for Zerenex (ferric citrate) by 3 months, to September 7, following revisions to Keryx’s new drug application.
Read NowInsights - A key biotech ETF broke through some key resistance levels on Thursday, which is good for the sector. Can it overcome broader market concerns?
Read NowInsights - Shares of Intercept Pharmaceuticals (ICPT) dropped early this week when documents attained through an FOIA request were made public, painting a picture of a management … Continue Reading
Read NowInsights - Before we get into the event of the week – the ASCO abstract drop on Wednesday evening – lets take a look at what’s been … Continue Reading
Read NowInsights - PropThink published an ASCO 2014 preview early this week, highlighting events that will capture Wall Street’s interest as abstracts are published online and presentations kick off at … Continue Reading
Read Now
